Galderma Group AG

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

-

Market Cap

43.40 Bil.

P/E Ratio

75.05

Dividend Yield

0.22 %

Earnings per Share

2.31 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE189 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 09:57:10 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW190186
PREV. DAY'S PRICE185 (07/20)
CHANGE DAY BEFORE
+4.00
2.16 %
52 WEEK HIGH / LOW (-) (-)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
-0.220.902.31--
DIVIDENDS PER SHARE
-0.160.37--
DIVIDEND YIELD IN %
-0.15 %0.22 %--
DIVIDEND GROWTH IN %
--137.58 %--
PRICE - EARNINGS RATIO
-117.5075.05--
PRICE - BOOK RATIO
-3.385.89--
PRICE - SALES RATIO
-6.168.88--
PRICE - CASH FLOW RATIO
-55.6939.04--
Further Key Figures

Master Data

WKN
A407X6
ISIN
CH1335392721
SYMBOL
PY3
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
GALDERMA GRP AG
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
Swiss Franc
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
234.57 Mil.
MARKET CAPITALISATION
43.40 Bil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
0.00 %
0.54 %
10.65 %
-----
HIGH187.00204.00204.00-----
LOW180.00180.00162.00-----

Dividende

pro Aktie

Company profile

Galderma Group AG engages in the provision of science-based premium dermatology solutions. The firm is also involved in delivering a synergistic portfolio of flagship brands spanning the full spectrum of the fast-growing self-care dermatology market. The company was founded in 1981 and is headquartered in Zug, Switzerland.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.